Latest Period
Q4 2025
Security Snapshot
KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS) Institutional Ownership
CUSIP: G52441105
13F Institutional Holders and Ownership History from Q1 2025 to Q1 2026
Institutions Reporting
107
Shares (Excl. Options)
56,150,702
Price
$26.52
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / COMMON STOCK
- Symbol
- KMTS on Nasdaq
- Shares outstanding
- 58,516,314
- Price per share
- $17.87
- All holders as of 31 Dec 2025
- Q4 2025
- Total 13F shares
- 56,150,702
- Total reported value
- $1,489,187,421
- % of total 13F portfolios
- 0%
- Share change
- +5,188,231
- Value change
- +$139,802,244
- Number of holders
- 107
- Price from insider filings
- $17.87
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK is tracked under CUSIP G52441105.
- 107 institutions reported positions in Q4 2025.
- 4 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 107 to 53 between Q4 2025 and Q1 2026.
- Reported value moved from $1,489,187,421 to $178,994,547.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 107 institutions filings for Q4 2025.
Investment Quick Answers
What is CUSIP G52441105?
CUSIP G52441105 identifies KMTS - KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP G52441105:
Significant Owners of KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Bain Charger Holdings, L.P. | 43% | -18% | $554,798,330 | -$40,705,389 | 25,172,338 | -6.8% | Bain Charger Holdings, L.P. | 31 Dec 2025 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 10% | +34% | $118,981,139 | +$31,879,630 | 5,968,664 | +37% | T. Rowe Price Associates, Inc. | 31 Mar 2026 |
| FMR LLC | 10% | +65% | $96,158,179 | +$38,804,570 | 5,225,988 | +68% | FMR LLC | 30 Sep 2025 |
| Endeavour Medtech Growth II LP | 4.2% | -20% | $53,974,682 | -$4,362,972 | 2,448,942 | -7.5% | Endeavour Medtech Growth II LP | 31 Dec 2025 |
As of 31 Dec 2025, 107 institutional investors reported holding 56,150,702 shares of KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS). This represents 96% of the company’s total 58,516,314 outstanding shares.
Top 25 Institutional Shareholders
The largest institutional shareholders of KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS) together control 92% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Bain Capital Investors LLC | 43% | 25,172,338 | -6.8% | 14% | $667,570,404 |
| FMR LLC | 10% | 5,851,644 | +11% | 0.01% | $155,185,599 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 7.5% | 4,369,429 | +138% | 0.01% | $115,878,000 |
| ANDERA PARTNERS | 4.3% | 2,540,106 | 0% | 38% | $67,363,611 |
| Yu Fan | 3.9% | 2,282,519 | 0% | 66% | $60,532,404 |
| BROWN ADVISORY INC | 2.9% | 1,688,356 | +34% | 0.06% | $44,775,208 |
| ALLIANCEBERNSTEIN L.P. | 2.4% | 1,426,055 | -4.4% | 0.01% | $37,818,979 |
| Omega Fund Management, LLC | 2.3% | 1,373,591 | -17% | 13% | $36,427,633 |
| VANGUARD GROUP INC | 2.2% | 1,274,330 | +69% | 0% | $33,795,232 |
| EVENTIDE ASSET MANAGEMENT, LLC | 2.2% | 1,269,651 | +5.4% | 0.53% | $33,671,280 |
| BlackRock, Inc. | 2.1% | 1,234,686 | +44% | 0% | $32,743,873 |
| FRANKLIN RESOURCES INC | 1.6% | 951,008 | +181% | 0.01% | $25,220,739 |
| Hood River Capital Management LLC | 0.96% | 560,457 | +42% | 0.16% | $14,863,320 |
| FEDERATED HERMES, INC. | 0.9% | 525,000 | +31% | 0.02% | $13,923,000 |
| NEXT CENTURY GROWTH INVESTORS LLC | 0.8% | 465,845 | +155% | 0.86% | $12,354,209 |
| Driehaus Capital Management LLC | 0.79% | 463,061 | 0.08% | $12,280,378 | |
| STATE STREET CORP | 0.75% | 436,147 | +58% | 0% | $11,566,618 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.72% | 419,115 | +26% | 0% | $11,116,875 |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 0.6% | 350,000 | 0.26% | $9,282,000 | |
| PERCEPTIVE ADVISORS LLC | 0.49% | 285,000 | 0.14% | $7,558,200 | |
| GOLDMAN SACHS GROUP INC | 0.47% | 272,452 | +277% | 0% | $7,225,427 |
| UBS Group AG | 0.46% | 270,058 | +35% | 0% | $7,161,938 |
| JENNISON ASSOCIATES LLC | 0.37% | 219,355 | +15% | 0% | $5,817,295 |
| MILLENNIUM MANAGEMENT LLC | 0.37% | 217,138 | -1.2% | 0% | $5,758,500 |
| SEI INVESTMENTS CO | 0.33% | 193,363 | +51% | 0.01% | $5,127,987 |
Institutional Holders of KESTRA MEDICAL TECHNOLOGIES, LTD. - COMMON STOCK (KMTS) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 8,983,203 | $178,994,547 | +$6,888,851 | $19.93 | 53 |
| 2025 Q4 | 56,150,702 | $1,489,187,421 | +$139,802,244 | $26.52 | 107 |
| 2025 Q3 | 48,395,709 | $1,149,884,732 | +$50,205,342 | $23.76 | 79 |
| 2025 Q2 | 47,375,461 | $785,486,291 | +$35,826,645 | $16.58 | 73 |
| 2025 Q1 | 44,838,936 | $1,117,387,025 | +$1,117,073,033 | $24.92 | 63 |